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2“Prediction is very difficult, especially if it’s about the future”
Niels Bohr
Preface
To cope with an unpredictable variety of potential pathogenic insults, the immune system
must generate an enormous diversity of recognition structures, and it does so by making
stepwise modifications of key genetic loci in each lymphoid cell. This proceeds through the
action of lymphoid-specific proteins acting together with the general DNA-repair machinery
of the cell. Strikingly, these general mechanisms are usually diverted from their normal
functions, being used in rather atypical ways in order to privilege diversity over accuracy. In
this Review, we focus on the contribution of a set of DNA polymerases discovered in the last
decade to these unique DNA transactions.
Introduction
Starting from their development in the bone marrow, B cells undergo a series of complex
molecular events to generate mature B cells that express a single functional B-cell receptor
(BCR). After antigen encounter, B cells can remain for the life of the host in the memory B-
cell compartment to provide protection from infection (Fig.1). For this to occur, B cells must
first generate a diverse pre-immune repertoire of BCRs for recognition of the diverse
antigenic world. In mice and humans, this repertoire is generated by ongoing rearrangement
of a large pool of variable (V) gene segments (around 50–100) and a small pool of diversity
(D) and joining (J) units (around 10) that combine to form the BCR by a process known as
V(D)J recombination1. Activation of B cells by foreign antigen induces a new cascade of
genomic modifications in the responding B cells. These involve the introduction of point
mutations in the V regions of the rearranged antibody to improve its affinity for the antigen (a
process known as somatic hypermutation (SHM)), as well as a switch in the DNA that
encodes the constant (C) region of the immunoglobulin heavy chain, from Cµ to another
heavy chain, Cγ, Cα or Cε, to provide appropriate effector function2 (a process known as
class-switch recombination (CSR)). SHM and/or a third type of DNA modification known as
gene conversion, are also used in some species that have more restricted numbers of germline
V gene segments to generate the pre-immune BCR repertoire3 (Fig.1).
In this Review, we focus on a specific set of enzymes — DNA polymerases — that are
mobilized during these different DNA transactions in B cells. New DNA polymerases have
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3been described in the last decade, and several of them have now been shown to have a distinct
role in the adaptive immune system. We describe the variety of enzymatic activities carried
out by DNA polymerases that contribute to immunoglobulin gene diversity either through the
processing of DNA junctions or through mutagenesis.
DNA polymerases
DNA polymerases are enzymes that synthesize new DNA strands using a DNA template.
DNA polymerases act in semi-conservative DNA replication and in various DNA-repair
pathways that require de novo DNA synthesis. Escherichia coli encodes five polymerases
(PolI to PolV), two of which are involved in replication, with the other three being involved in
DNA repair, DNA damage tolerance and stress-induced mutagenesis4. By contrast, mammals
have 14 such enzymes (or 15, if one includes terminal deoxynucleotidyl transferase (TdT), a
template-independent polymerase). Four are replicative polymerases (Polα, Polγ, Polδ and
Polε) and 11 perform various non-replicative tasks5,6 (Table 1). These non-replicative
functions concern the removal and repair of damaged bases (for example, Polβ in base-
excision repair), the rejoining of broken DNA ends (Polλ and Polµ in non-homologous end-
joining (NHEJ)), the by-pass of DNA lesions that block the progression of replication forks
(Y family polymerases, as well as Polζ, in translesion DNA synthesis (TLS)) and template-
independent insertion of nucleotides (TdT during V(D)J recombination). One hypothesis
proposed for the striking increase in the number of non-replicative polymerases in higher
vertebrates compared with prokaryotes is that each polymerase would display a preferential
handling of specific DNA lesions, for which it would harbour both higher efficiency and
accuracy, thereby reducing the deleterious consequences of the corresponding damage7.
V(D)J recombination  and DNA polymerases
A complete V gene sequence of the BCR is assembled from dispersed V, D and J coding
segments for the heavy chain, and V and J elements for the light chain. This recombination
process is mediated by the lymphoid-specific genes recombination-activating gene 1 (RAG1)
and RAG2, which ensure that the process is targeted to antigen-receptor loci, together with
the general NHEJ machinery of the cell. The ubiquitous NHEJ machinery mediates several
essential steps: the binding of DNA ends, their processing and their proper religation.
Extensive modifications that occur at DNA ends before the continuity of the immunoglobulin
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4coding sequence is restored are the hallmark of V(D)J recombination, and the enzymatic
activities involved are discussed below.
The rearrangement process. The assembly of a complete immunoglobulin V gene involves
the introduction of double-strand breaks (DSBs) in the DNA at the border of each coding
element followed by rejoining of the ends8, 9 (Fig. 2). For this to occur, a synapsis forms
between the two distantly located genomic regions and the DNA is cleaved by a process
involving the two RAG proteins. The RAG1/RAG2 complex binds to conserved elements in
the DNA known as recombination signal sequences (RSSs) that flank each coding segment
(V, D and J segments) and introduces a nick into one strand of the DNA between the RSS and
the coding sequence. The nick creates a free 3’ hydroxyl group, which attacks the
phosphodiester bond on the opposite strand, forming the DSB. This cleavage generates two
coding ends that terminate in a covalently sealed hairpin and two blunt signal ends. The signal
ends remain associated with the RAG complex, which serves as a scaffold to recruit factors
that religate the ends — by the NHEJ pathway — to generate a circular episome that will
eventually be eliminated. The hairpin coding ends, also synapsed by the RAG complex, are
encircled by the Ku proteins (Ku70 and Ku86), which recruit DNA-PKcs (DNA-dependent
protein kinase catalytic subunit), which in turn recruits and activates Artemis, enabling it to
open the hairpin ends.
In most places in the genome, the DSBs are then resolved by rendering the DNA ends
compatible for their religation. However, at the antigen-receptor loci, the coding ends are
subjected to extensive ‘nibbling’ (nucleotide trimming) by as-yet-undefined exonucleases
followed by DNA resynthesis by template-dependent polymerases, and random nucleotide
insertions (N-additions) by the template-independent polymerase TdT. These different
enzymatic activities create diversity by varying the number of amino acids in the
complementarity-determining region 3 (CDR3) of the antigen receptor, a region that makes a
major contribution to the specificity of the antibody produced. Finally, the strands are
religated and the coding joint formed by the activities of XRCC4 (X-ray repair cross-
complementing protein 4) in complex with Cernunnos (also known as XLF) and DNA ligase
IV10.
Random pairing of the rearranged heavy and light chains then occurs during assembly
of the antibody molecule to create different specificities. It should be emphasized that the
junctional variability generated during V(D)J recombination at the heavy chain locus exceeds
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segments and the combination of heavy-chain and light-chain pairing.
Here we focus on the role of DNA polymerases during the rearrangement process of
the BCR and we start by summarizing our current knowledge of the role played by the PolX
family (which comprises Polβ, Polλ, Polµ and TdT in mammals). Owing to their capacity to
interact with DNA-PKcs complexed to DNA, Polµ and Polλ have emerged as possible
partners of both general NHEJ and V(D)J recombination11, 12. Polβ in contrast seems to be
mainly involved in BER13.
PolX polymerases in NHEJ. Polymerases are required during the repair of DSBs by NHEJ to
fill in gaps in the DNA or to extend recessed 3’ ends. In the yeast Saccharomyces cerevisiae,
the Pol4 enzyme, which belongs to the PolX family, has been shown to be involved in fill-in
DNA synthesis during NHEJ14. Among PolX polymerases, Polλ is closer to yeast Pol4 while
Polµ and TdT, which are highly homologous to each other, are more distantly related15-17.
Polµ and Polλ are expressed in most tissues, with enhanced expression of Polµ found in
lymphoid cells, whereas TdT is exclusively expressed in developing B and T cells.
Several laboratories have studied the role of PolX polymerases during DSB repair.
Polµ and Polλ have been shown to associate with the protein complex Ku–DNA-PKcs once
they are bound to DNA and can perform gap-filling synthesis of paired DNA ends in vitro11, 12,
18. The possible use of these enzymes during NHEJ seems to be due to their capacity to
synthesize DNA from less stable primer structures compared to replicative polymerases, such
as primers that encompass a DNA template with a gap19 (Fig.3c). Lieber and colleagues, using
purified polymerase proteins in vitro, showed that a competitive hierarchy exists in the
recruitment of polymerases to the DNA during NHEJ, with Polµ being preferentially recruited
over Polλ in the absence of TdT, whereas the reverse was true when TdT was present12.
Ramsden and colleagues proposed the existence of a range of increasing template dependence
among mammalian PolX family members, with TdT showing the least template dependency,
then Polµ and then Polλ, which shows higher template dependence20. Accordingly, in their
assay, Polµ has the unique capacity to prime DNA synthesis across a junction without any
base pairing (Fig.3c).
Paradoxically, the absence of these polymerases induces no sensitivity to DSB-
inducing agents, as embryonic fibroblasts derived from mice lacking either or both Polµ and
Polλ were not sensitive to ionizing radiation21. This implies that other processing activities
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6can substitute and provide efficient DSB repair, although the outcome of DSB rejoining may
be qualitatively different.
The nibbling process during V(D)J recombination. The CDR3 that is generated during the
rearrangement process displays a size heterogeneity that is more marked for the heavy chain
(15 to 55 base pairs) than for the light chain (20 to 30 base pairs). Such size differences imply
a variable trimming of the coding ends before religation, but the enzyme responsible for this
activity has not yet been formally characterized. It has been proposed that a splicing variant of
TdT may have such exonuclease activity22, but biochemical and functional assays have
challenged this idea23, 24. During NHEJ, Artemis forms a complex with DNA-PKcs, which
phosphorylates Artemis and allows it to acquire an endonucleolytic activity acting on 3’ or 5’
overhanging ends and on various branched DNA structures. This role for Artemis explains the
general radiosensitivity observed cells that lack this protein25, 26. Artemis cleaves RAG-
induced hairpin ends preferentially 3’ from the tip in vitro25. In vivo, this cleavage results in a
small palindrome sequence (referred to as P addition) at the coding end of the
immunoglobulin gene segments. Once the hairpin has been cleaved, Artemis could be
responsible for nucleotide trimming at the 5’ and 3’ ends of the coding ends, but the
involvement of additional exonucleases has not been ruled out. We found no effect of
inactivation of the exonuclease Exo1 on the size of the CDR3 of heavy-chain V regions (C.-
A. Reynaud and J.-C. Weill, unpublished observations, in collaboration with W. Edelmann),
but other enzymes, such as TREX1 (three prime repair exonuclease 1)27, remain to be
assessed.
PolX polymerases during V(D)J recombination. A role for Polµ and Polλ polymerases in the
V(D)J recombination process has been assessed by the analysis of immunoglobulin
rearrangement in mice deficient for these enzymes, alone or in combination. We reported that
light-chain junctions were shorter by about 6 base pairs in the absence of Polµ, whereas the
size of heavy-chain junctions was not affected28. These altered light-chain junctions resulted
in an impaired pre-B-cell to B-cell transition, at which stage light-chain genes rearrange, as
well as a moderate and more variable peripheral B-cell deficiency. Surprisingly, Polλ-
deficient mice had normal light-chain joints but heavy-chain junctions that were about 5 base
pairs shorter, although no quantitative effect on the B-cell population was observed21.
Nucleotide additions were unaffected in the absence of Polλ, suggesting that Polλ was acting
H
AL author m
anuscript    inserm
-00281241, version 1
7before TdT-mediated nucleotide addition and was therefore not involved in filling the gaps
generated by 3’ TdT-mediated extensions. Mice deficient in both polymerases displayed the
additive effects of both phenotypes, without any further decrease in junction size or B-cell
deficiency21. Together, these studies suggest that Polµ  and Polλ  act on different
immunoglobulin chains: Polµ on the light chain and Polλ on the heavy chain. During B-cell
ontogeny, Polλ and Polµ are expressed at similar levels at the pro-B-cell stage, when heavy-
chain gene rearrangement takes place, whereas Polµ expression increases 25-fold at the stage
when the light chain genes rearrange. By comparison, there is a several hundred-fold higher
expression of TdT at the pro-B-cell stage, when N-additions are made, compared with later
differentiation steps, indicating that the recruitment of these different enzymes may be
dictated by both their relative affinity for DNA and their respective expression level.
Exactly how Polλ and Polµ participate in V(D)J recombination remains to be
elucidated (Fig. 3). Their role could involve protecting the DNA ends from an exonuclease or,
as proposed for Polµ, filling in gaps in the DNA at junctions with minimal homology, or
possibly both20, 21. Whatever their exact roles, the fact that the immune system has evolved
two different polymerases for each chain of the BCR is an unexpected finding. We have
proposed that their precise interventions may be linked to the particular property of each
CDR321. For light chains, a restricted heterogeneity of CDR3 sizes is indeed required to
maintain a semi-invariant residue encoded at the 3’ end of Vκ genes29, whereas CDR3
heterogeneity is key for the heavy-chain repertoire. Minimal processing of light-chain coding
ends would be tightly controlled by Polµ, whereas a less potent activity of Polλ would allow
for the large size diversity that is characteristic of CDR3s of immunoglobulin heavy chains.
Somatic hypermutation and DNA polymerases
In the 1950s, SHM was proposed as a central player in the immune system either to improve
the primary repertoire or to mature a specific immune response30, 31. It was not until decades
later that mutations were actually observed, first in the immunoglobulin protein32 and then at
the DNA level33-36, providing proof that a process of adaptive mutation targeted to a single
locus, not observed in any other living organism, was co-opted by the immune system.
One of the central problems researchers faced when trying to understand SHM was the
nature of the enzymatic activity involved37. The discovery of activation-induced cytidine
deaminase (AID) provided a clue to this problem38-40. It is now generally accepted that the
deamination of cytidines into uracils by AID is the initiating event that allows the specific
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8recruitment of factors involved in SHM, CSR or gene conversion41. Uracils can normally be
excised by several uracil glycosylases and replaced by the base-excision repair pathway,
which faithfully restores the original DNA sequence. By contrast, during SHM, the uracils
generated by AID can be recognized either by uracil-DNA glycosylase (UNG) or, as U-G
mispairs, by the mismatch repair complex. However, both repair pathways appear to function
abnormally. Effectively, the action of UNG is restricted to uracil excision, giving rise to
abasic sites, and, for mismatch repair, the mismatch-binding moiety (MSH2–MSH6, together
with Exo1) proceeds alone without recruiting the effector part of the complex
(MLH1–PMS2)42-44. These two repair pathways therefore trigger further DNA alterations
through mutagenic DNA synthesis, rather than their normal role in correcting the error to
match the original sequence (see model proposed below). Evidence for the involvement of
mutagenic polymerases in these atypical repair processes is reviewed in the following
sections, and a model is proposed based on our knowledge of the different partners involved.
Candidate polymerases for SHM. The first candidate polymerase known to lack proofreading
activity and to act outside the S phase of the cell cycle was Polβ. As Polβ-deficient mice die
after birth, reconstitution of the immune system of irradiated animals with Polβ-deficient fetal
liver cells was carried out, but this failed to reveal any deficiency in the SHM process45.
Another group of polymerases — namely the TLS polymerases46-48 — were considered
good candidates for being involved SHM. These enzymes can mediate polymerase activity
opposite DNA lesions that induce a stalling (pausing) of the replication fork. Because of their
relaxed catalytic sites that allow them to accommodate distorted DNA structures, TLS
polymerases are highly error-prone when copying normal undamaged DNA. Although studies
of TLS have been largely focused on polymerases of the Y family (together with Polζ), other
enzymes, such as Polµ, Polλ and Polθ, have shown robust translesion activity in vitro49-51.
Each non-replicative polymerase (except Polν) has been tested for its role in SHM. Since
most of these enzymes have a specific mutagenic signature in vitro, when copying normal
DNA or when by-passing abasic sites, one should expect that inactivation of a polymerase
involved in SHM would result in a modification of the immunoglobulin gene mutation pattern
in a manner that reflects its enzymatic preferences.
Polη. The study of patients affected by the xeroderma pigmentosum variant (XP-V)
syndrome, a genetic disease associated with the inactivation of polη52, 53, provided the first
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9experimental evidence for the involvement of a TLS polymerase in SHM. A reduced mutation
frequency at A/T bases was observed in these patients54, 55, an observation that was further
confirmed in Polη-deficient mice56-58 (Fig.4).
The preferred mutation of Polη  when copying normal DNA in vitro is the
incorporation of Gs opposite Ts, thereby generating T to C and A to G transition mutations,
the complementary mutation (that is, the incorporation of Cs opposite As) being 10 times less
frequent59. Altogether, the nucleotide misincorporation frequency of Polη is 2–3%, with Ts
mutated 2–2.5 times more frequently than As, and Cs plus Gs about 3–4 times less frequently
than both As and Ts. Polη is not a processive enzyme and therefore favours the synthesis of a
few nucleotides (short-patch DNA synthesis). Mutagenicity of Polη was estimated using a Vκ
template sequence when synthesizing either the transcribed or the non-transcribed strand in
vitro60. Interestingly, despite the fact that this assay monitored the error rate of the polymerase
during the synthesis of a few hundred bases that may not occur in vivo, a strong correlation
with the in vivo pattern of mutations at A/T base pairs was observed, in particular during
synthesis of the coding strand (the non-transcribed strand), although hotspots on both coding
and non-coding strands were clearly observed. This suggested that both strands could be
copied by Polη in vivo, possibly with some bias for the coding strand.
A residual A/T mutagenesis (10–15%) is observed in Polη-deficient mice, suggesting
that other polymerase activities might contribute to the formation of mutations at A/T bases56.
Half of these mutations consist in A to C and T to G transversion mutations, a pattern that
evokes the signature of another TLS enzyme, Polκ61, 62(Fig.4). As Polκ does not seem to play
a role in the physiological situation63, 64, it suggests that this polymerase acts as a back-up
when the normal pathway is compromised. Accordingly, the reduction in A/T mutagenesis
corresponds well with the lower mutagenicity of Polκ61, 62. Altogether these data support the
proposition that Polη is the sole contributor of A/T mutations during physiological SHM in
mice, with other TLS polymerases playing a backup role65.
Rev1. Rev1 has a deoxycytidyltransferase activity that is directed opposite various damaged
bases, as well as abasic sites and normal DNA66, 67. The Rev1 protein contains an N-terminal
domain that is unique among other Y family enzymes46 (known as BRCA1 C-terminal
(BRCT), which is involved in protein–protein interactions) and a C-terminal region that
mediates interaction with other TLS polymerases68. Deletion of the BRCT domain of Rev1
has been shown to be required for TLS activity of certain DNA lesions, although it does not
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seem to be required for SHM69. By contrast, the complete deficiency of Rev1 has a clear
effect on SHM70. G/C mutations represent around 50% of all mutations during SHM, among
which approximately 25% are G to C and C to G transversion mutations that could correspond
to the mutation signature of Rev1 when bypassing abasic sites. Surprisingly, in Rev1-deficient
mice, C to G mutations were almost absent from the coding strand, whereas G to C mutations
were only reduced (by around 50%), suggesting a different use of Rev1 depending on the
strand synthesized and the implication of another polymerase for generating the remaining C
to G mutations. As these mutation data were obtained using functional Vλ1 sequences,
analysis of unselected mutations would be useful to confirm this strand bias. These data
therefore indicate that other polymerases, in addition to Rev1, are responsible for generating
transversions mutations at G/C bases.
Polζ. Polζ  is composed of two subunits –Rev3, the catalytic subunit, and Rev7– and is a
major partner in the bypass of DNA lesions. It has been proposed that polζ could work as a
general DNA extender in lesion bypass performed by other TLS enzymes, being able to
synthesize a few nucleotides before the replication fork restarts its progession71. Moreover,
Polζ is the only TLS polymerase that when inactivated in mice is embryonic lethal, indicating
that this enzyme has other functions beyond TLS activity72-74. It was recently reported that the
activity of Rev3 is error-prone when copying undamaged DNA, albeit to a lesser extent than
Polη and Polι75. However, it should be noted that all biochemical assays on Rev3 are
performed using the yeast enzyme, as no active recombinant mammalian Rev3 has been
produced so far. In transgenic mice expressing an antisense transcript against Rev3 that
reduces its expression in B cells, a lower mutation frequency was observed, with no specific
impact on the mutation pattern76. A similar observation was made in a Burkitt’s lymphoma
cell line (CL-01) that is induced to undergo SHM in culture, using antisense oligonucleotides
against Rev377.  Mice with conditional Rev3 inactivation, allowing its deletion in mouse B
cells, were recently generated. Rev3 deficiency impaired B-cell proliferation, presumably due
to a defect in the maintenance of genome stability, as Rev3-deficient B cells frequently
harboured chromosomal aberrations. A decreased SHM frequency was observed, but again
with no obvious change in the SHM pattern78.
Taken together, these results can be interpreted in two ways. First, Polζ could be a
major partner in all the mutations produced during SHM. This is a feasible scenario because it
could participate in extending the short-patch DNA synthesis performed by Polη and the
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bypass of abasic sites. Second, the effect of the Rev3 deficiency observed could be indirect,
being due instead to the altered cell viability caused by the absence of Polζ.
Polι. Like Polη, Polι tends to incorporate a T opposite a G when copying normal DNA79.Polι
is ten-fold more potent than Polη in generating this error, although recent data suggest that its
fidelity may vary considerably depending on the nature of the divalent ionic cofactor present
in the reaction80.
Human Burkitt’s lymphomas undergo SHM in culture either constitutively (Ramos
cell line) or after induction (BL2 or CL-01 cell lines)81-84. The pattern of mutations does not
mimic the SHM pattern generated in vivo as it displays more mutations at G/C base pairs
(80% versus 20% at A/T base pairs). It seems therefore that the A/T pathway does not
function properly in these cell lines despite the presence of a functional mismatch repair
pathway and normal Polη expression85. Strikingly, SHM could no longer be induced when
Polι was inactivated in the BL2 cell line86. In contrast, SHM was found to be normal in mice
deficient for Polι (a deficiency generated by a spontaneous stop codon mutation occurring in
the 129 mouse strain), thus excluding Polι as a physiological partner of hypermutation in the
mouse87. Therefore, in BL2 cells, Polι may be involved in an error-prone repair pathway
mediated by UNG, similar to what occurs for Polη in MSH2-deficient mice (see model
below). Accordingly, BL2 subclones displaying increased Polβ expression fail to induce
SHM, suggesting that Polβ could displace Polι to perform its normal error-free repair
function88.
Polθ. Two groups have reported contrasting results on the impact of a complete inactivation
of Polθ on SHM in mice. In one report, deletion of Polq (the gene encoding Polθ) leads to a
large decrease in the frequency of mutations, with a pattern biased towards transition
mutations89. In another report, deletion of this gene only induces a moderate reduction in
mutation frequency, without alteration of the pattern of mutations90. Moreover, deletion of
both Polθ and Polη did not further modify the mutation profile seen in Polη-deficient mice91.
Deletion of the sole polymerase domain of Polθ  also resulted in a mild phenotype, with a
small increase of A/T mutagenesis but no alteration of the G/C mutation profile92, a result
that, again, does not fit well with the robust translesional activity of Polθ at abasic sites in
vitro and its preference for insertion of As51. Additional experiments are therefore needed to
clarify whether there is a direct role of Polθ during SHM.
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PCNA. Proliferating cell nuclear antigen (PCNA) is a sliding clamp that tethers DNA
polymerases to the DNA template during replication. PCNA is monoubiquinated at lysine
residue 164 in human cells after UV-irradiation, and it has been proposed that this
modification may mediate the exchange between replicative and TLS polymerases when the
replication fork arrests at a lesion93. Accordingly, TLS polymerases bind to
monoubiquitinated PCNA through two types of motif: a PCNA interacting peptide (PIP box)
that binds directly to PCNA94 and an ubiquitin-binding motif that is required for their bypass
function95. The role of PCNA in SHM was analysed using mice bearing a PCNA mutation
(Lys164Arg) that is known to inhibit its monoubiquitination and therefore its interaction with
TLS polymerases. Mutations at A/T bases were found to be practically absent96. Mutations at
G/C bases were mildly affected, with only a 50% reduction of C to G transversion mutations
and no alteration of other types of G/C mutations, including G to C transversions. When these
results are compared with those observed for Rev1-/- mice, they imply that, for C to G
mutations, bypass of half of the abasic sites on the coding strand can be accomplished by
Rev1 independently of a monoubiquitinated form of PCNA. MSH2 and UNG also have a PIP
box, and it has been shown that PCNA can be recruited in specific DNA processes, such as
mismatch repair or base-excision repair which takes place outside DNA chromosomal
replication97. However it is not known whether PCNA is monoubiquinitated during these
processes. The contribution of the monoubiquitination of PCNA during SHM appears
therefore somewhat paradoxical, being required during the short-patch DNA synthesis
performed by Polη, but almost dispensable during the bypass of abasic sites that represents a
classical TLS process.
UNG, MSH2 and the A/T mutagenesis pathway
The uracils generated by AID are processed by only two pathways, UNG and mismatch
repair, as clearly established by Neuberger and colleagues. These authors used UNG/MSH2
double-deficient mice98 to show that uracils generated by AID are carried over into replication
without processing, to generate only G to A and C to T transition mutations (Fig.4). These
mutations therefore represent the footprint of AID deamination at the immunoglobulin locus.
UNG deficiency alone shifts mutagenesis at G/C bases towards transition mutations,
with a minor impact on A/T mutations99 (Fig. 4). By contrast, MSH2 deficiency results in a
decreased mutagenesis at A/T bases, a phenotype that is also associated with MSH6 and Exo1
H
AL author m
anuscript    inserm
-00281241, version 1
13
deficiency100-103 (but which is not observed in the absence of PMS2 or MLH1, the effector
partners of the mismatch repair complex)42, 104. These contrasting phenotypes led to the
proposition of two alternative phases of SHM: one mediated by UNG and generating
mutations at G/C bases after uracil excision, and one mediated by MSH2–MSH6, introducing
A/T mutations98. However, alteration of the mutation pattern in MSH2-deficient animals
appears to be more complex: in addition to a reduced A/T mutagenesis, it shows an overall
reduced mutation frequency, an increase in transition mutations at G/C bases, and an altered
mutation profile showing an increased targeting at a few hotspot positions (Fig.4). For a long
time, no comprehensive explanation was provided for this complex phenotype, which was
described before the discovery of AID. However, when compared to the footprint of AID
targeting revealed in Ung-/-Msh2-/- mice, this profile can be simply explained by an increased
error-free repair mediated by UNG in the absence of MSH2–MSH6, thus reducing the overall
number of mutations65. Inefficient displacement of AID from its target DNA would explain
the increase in G/C transition mutations (uracils being carried over to replication), especially
at a few hotspot positions showing a symmetrical WGCW structure (W standing for A or T).
The residual A/T mutagenesis appears to be generated by an error-prone repair mobilizing
UNG and Polη, as clearly shown by the complete absence of A/T mutations in MSH2/Polη
double-deficient mice65 (Fig.4), but whether this UNG-mediated error-prone repair is
artificially caused by the absence of MSH2 is an open question.
A model for SHM: two competitive rather than alternative pathways
The following model attempts to bring together data obtained from mice deficient in TLS
polymerases, mismatch repair, Exo1 and UNG (Fig.5).
In this model, AID attacks the V gene segment undergoing SHM, introducing uracils
on both strands of the DNA most probably during a few rounds of replication. Because AID is
expressed throughout the cell cycle105, this attack can occur in the different phases of the cell
cycle. Uracils generated during the G1 phase are preferentially recognized as U-G mismatches
by the MSH2–MSH6 complex. If this complex is absent, UNG will process most of the
uracils and repair them error free. In wild-type cells, the MSH2–MSH6 complex recruits
Exo1103, to excise a patch of DNA from a single-strand nick, the origin of which is yet
unknown, as well as Polη, which results in mutagenic synthesis of the strand targeted by AID.
AID deaminates 60% of Cs on the coding strand and 40% on the non-coding strand98, whereas
the G:C mutation ratio is reequilibrated after Polη intervention (Fig.5). Together with As
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being mutated about twice as frequently as Ts, this suggests that Polη exerts its activity more
frequently on the coding strand, and possibly extends a longer patch of DNA on this strand.
The equivalent mutation frequency observed at the V gene segment for wild-type and
MSH2/UNG-deficient mice suggests that, in general, every uracil that is repaired by the
mismatch-repair pathway gives rise to a distant mutation. It has been proposed recently, using
a transgenic model, that A/T mutations are only produced on targeting of the coding strand106.
Whereas such a strand-specific repair would be compatible with the equalization of mutations
between G and C bases, and the A over T bias observed in V gene mutations (Fig.4), the
proposition deserves additional studies, as the mutations reported do not fit with the pattern
expected from Polη-mediated repair60.
Uracils that remain during replication or those that are generated in S phase, while
present in single-stranded DNA, will be processed by UNG. As the replication fork proceeds,
it will stall opposite the abasic site generated by UNG and will recruit TLS polymerases in a
classical TLS bypass process, although it is surprisingly largely independent of PCNA
monoubiquitination. So the question remains: which polymerases, besides Rev1, might create
mutations at these abasic sites? Transition mutations could be produced opposite uracils by
the replicative polymerases, but it is also possible that UNG might excise most of them and
that several TLS polymerases could follow the “A rule” opposite an abasic site (a default
pathway leading to insertion of A opposite a lesion4), and thus also produce G to A and C to T
transition mutations. Polζ could also be involved in the bypass of these abasic sites, and a role
for replicative polymerases has been proposed as well107.
Rather than representing two alternative pathways for the handling of AID-mediated
deaminations, we therefore propose that the mismatch repair and UNG-mediated pathways
are competitive, with the MSH2–MSH6 complex restricting the role of UNG in the S phase to
the single-stranded configuration of uracils.
CSR, gene conversion and DNA polymerases
CSR occurs in activated B cells and allows the exchange of heavy chain constant region
genes, from Cµ to other downstream C regions (Fig.1). Specific sequences (switch regions)
that are located upstream of each constant region are involved in this recombination event that
requires the deamination of cytidine residues in these switch regions by AID. Uracils are
further processed by UNG and by mismatch-repair factors, the former having a more
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important role in CSR than in SHM, suggesting that the competition between these two
activities might differ during both processes.
Polη-dependent mutations have been observed upstream of switch junctions in human
and mouse B cells, but there does not seem to be any quantitative alteration in CSR in the
absence of this enzyme55-57, 108. As DNA sequences surrounding switch junctions have no
function once CSR has occurred, these mutations are likely to have no physiological role. It
was recently reported that, during CSR, error-free repair by Polβ after uracil excision could
compete with the generation of the DSBs that are required to initiate recombination109. Polη
(as well as Polκ if used as a back-up enzyme) lacks deoxyribophosphate-lyase (dRP-lyase)
activity to remove the sugar moiety left at an abasic site after incision of the sugar-phosphate
DNA backbone, whereas Polβ has such an activity, which allows it to contribute efficiently to
the base-excision repair process. Absence of this dRP-lyase activity could slow down the
ligation step after DNA synthesis by Polη and thus increase the occurrence of two nearby
nicks in DNA, generating DSBs.
Gene conversion is a non-reciprocal recombination event used by some species, such
as chickens and rabbits, to generate their pre-immune repertoire (Fig.1). V(D)J recombination
remains the initial event in these species, but it involves either a single or a restricted number
of V genes. Rearranged heavy- and light-chain genes are thereafter diversified by templated
gene conversion during the extensive proliferation of B cells in gut-associated lymphoid
tissues (bursa of Fabricius, Peyer’s patches and appendix)3. A virally transformed bursal B-
cell line, DT40, was reported to undergo ongoing gene conversion at its light chain locus in
culture110, 111, a process strictly dependent on AID activity112, 113. The DT40 cell line has also
become a popular model for studying hypermutation, notably upon removal of the pool of
donor genes, thus forcing the outcome of AID-induced deamination towards untemplated
mutagenesis114. However, the characteristics of this mutation process appear to diverge
substantially from physiological SHM (Box 1).
Gene conversion was significantly reduced in the chicken DT40 cell line after deletion
of Polη115. Considering the error rate of this polymerase during the copying of a normal DNA
template and the low frequency of untemplated mutations within gene conversion tracts, this
result appears rather paradoxical. One could imagine that the mutations introduced by Polη
will be corrected by mismatch repair, but the rationale for selecting an error-prone polymerase
for this process remains difficult to assess. It is tempting to speculate that Polη is recruited by
AID together with MSH2–MSH6 at U/G mismatches, this complex being somehow mobilized
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as a whole, whatever the outcome of the repair process116. Alternatively, this could reflect a
more general role of Polη in homologous recombination, as recently described in vitro117.
Conclusion
Bacteria use TLS polymerases to avoid irreversible replication blocks when other damage
avoiding strategies have failed7. By so doing, mutagenesis is favoured over cell death, and it
has been widely discussed that mutator phenotypes have an adaptive value in prokaryotes118,
119. The paradigm of the XPV syndrome, in which a TLS polymerase deficiency results in
sunlight sensitivity and an increased risk of skin cancers, suggests an alternative scenario in
higher organisms. Amplification of polymerases in higher vertebrates may have evolved to
ensure a specialization towards defined lesions for which each polymerase would be selected
for both efficiency and accuracy, thus avoiding deleterious mutations that could lead to cancer
in multicellular organisms. Strikingly, the adaptive immune system mobilizes TLS
polymerases in their ancient mutagenic role, mirroring during its fight against pathogens the
stress-induced adaptability of the prokaryotic world.
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BOX 1 | SHM in the DT40 cell line: “passive” versus “active” mutagenesis
The DT40 cell line is a chicken bursal lymphoma that undergoes high rate of activation-
induced cytidine deaminase (AID)-dependent gene conversion in culture110-113. Deletion of the
all pseudogenes upstream of the single functional Vλ gene deprives this cell line of all donor
sequences required in cis for gene conversion, and shifts the V-targeted modifications towards
mutations114. Mutagenesis observed in DT40 cells appears essentially “passive”, occurring by
saturation of the uracil-DNA glycosylase (UNG) repair pathway. Accordingly, deletion of
Ung in DT40 cells results in a sevenfold increase in mutagenesis120, implying that a large
fraction of the uracils generated by AID are repaired error-free, by base-excision repair or by
sister chromatin exchange. All mutations observed are targeted to G or C bases, being almost
exclusively transition mutations or G to C and C to G transversion mutations: they thus appear
to be generated during replication by copy of unrepaired uracils or by bypass of abasic sites,
performed by Rev1 in a translesion process that appears strictly dependent on PCNA
monoubiquitination121, 122. This cell line therefore does not mimic the “active” SHM process
— in which the MSH2–MSH6 complex recruits Polη to generate mutations at A/T bases and
the bypass of abasic sites involves TLS polymerases other than Rev1 — but it nevertheless
reproduces the initial steps of SHM consisting in the targeting of AID to the V region.
Glossary
BCR
B cell receptor. Refers to the Ig molecule present at the B cell surface, irrespectively of its
heavy chain isotype.
V(D)J recombination
Somatic rearrangement of variable (V), diversity (D) and joining (J) regions of the genes that
encode antigen receptors, leading to repertoire diversity of both T-cell and B-cell receptors.
gene conversion
A non-reciprocal homologous recombination event in which the donor gene(s) remains
unmodified and an acceptor gene acquires the recombined segment. In chickens, variable (V)
pseudogenes are donors that modify the functional, rearranged V gene in follicles of the bursa
of Fabricius to generate a diverse pre-immune repertoire.
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somatic hypermutation
A process by which antigen-activated B cells in germinal centres acquire point mutations
targeted to the variable regions of rearranged immunoglobulin gene segments. The B cells are
subsequently selected for those expressing the ‘best’ mutations on the basis of the ability of
the surface immunoglobulin to bind antigen. This process occurs in activated B cells in all
jawed vertebrates, but it also occurs in immature B cells in sheep to generate the pre-immune
repertoire.
class-switch recombination
(Class or isotype switching). A region-specific recombination process that occurs in antigen-
activated B cells. This takes place between ‘switch region’ DNA sequences located upstream
from each immunoglobulin heavy chain constant region genes and results in a change from
the IgM to one of the IgG, IgA or IgE immunoglobulin isotypes. This imparts flexibility to the
humoral immune response and allows it to exploit the different capacities of the
immunoglobulins to activate the appropriate downstream effector mechanisms.
translesion DNA synthesis
(TLS). Process that allows the bypass of DNA damage that otherwise blocks the progression
of the replication fork, through the replacement of the replicative polymerase with specialized
polymerases (known as TLS polymerases) that can copy non-instructive DNA lesions. TLS
polymerases have low fidelity on undamaged templates. Most TLS polymerases belong to the
Y family polymerases.
recombination-activating genes
(RAG1 and RAG2). RAG1 and RAG2 are involved in creating the synapsis and the double-
strand DNA breaks required for the assembly of the dispersed gene segments that encode the
complete protein chains of B-cell and T-cell receptors.
synapsis
Non-covalent juxtaposition of two non-adjacent stretches of DNA.
recombination signal sequences
(RSSs). Conserved elements that constitute recognition sites for the V(D)J recombinase
proteins, which are encoded by the recombination-activating gene 1 (RAG1) and RAG2. They
consist of a palindromic heptamer that is immediately adjacent to the coding gene segments
— V (variable), D (diversity) or J (joining) — and is separated by a 12- or 23-base-pair spacer
from a conserved nonamer sequence.
non-homologous end joining
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(NHEJ). The process that joins broken DNA ends without depending on extended homology.
Components of this pathway include the proteins Ku70, Ku80, Artemis, X-ray repair cross-
complementing protein 4 (XRCC4), DNA ligase IV, Cernunnos/XLF and the catalytic subunit
of DNA-dependent protein kinase (DNA-PKcs).
complementarity-determining regions
(CDRs). The three hypervariable antigen-receptor regions (in both chains of the T-cell and B-
cell receptors) that interact with the antigen. The third CDR (CDR3) is partly encoded by the
germline variable (V), diversity (D) and joining (J) regions of each receptor chain. Extensive
diversity is generated in CDR3 during gene rearrangement by nucleotide trimming and/or
template-independent nucleotide additions by terminal deoxynucleotidyltransferase.
base-excision repair
A DNA-repair pathway that removes single non-canonical bases from the DNA, such as
deaminated or oxidized bases, and replaces them with an appropriate base templated on the
opposite strand. Repair is initiated by a DNA glycosylase that is specialized for a particular
type of damage, and nucleotide replacement is performed by DNA polymerase β.
deamination
Removal of an amine group from a pyrimidine or purine nucleic-acid base. Deamination of
cytosine and adenosine yields uracil and inosine, respectively.
mismatch repair
A repair pathway that recognizes mismatched bases that arise in DNA because of errors made
by replicative DNA polymerases. These are then repaired by an excision system that removes
a tract of DNA including the mismatch, and re-copies the original strand. The mismatch repair
complex includes a mismatch-binding moiety (such as MSH2–MSH6), and an effector part
(such as MLH1–PMS2) that triggers excision of the mismatch-containing DNA sequence.
hotspot motif
A short DNA motif (DGYW or WRCH; where D denotes adenosine (A), guanosine (G) or
thymidine (T); Y denotes cytidine (C) or T; W denotes A or T; R denotes A or G; and H
denotes T, C or A) at which mutations are preferentially targeted during somatic
hypermutation.
replication fork
Site in double-stranded DNA at which the template strands are separated, allowing a newly
formed copy of the DNA to be synthesized, with the fork moving in the direction of leading
strand synthesis.
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abasic site
A common form of DNA damage in which a base is lost from a strand of DNA,
spontaneously or by the action of DNA repair enzymes such as uracil glycosylase, while
leaving the phosphodiester bond intact.
xeroderma pigmentosum
(XP). A rare inherited human disorder, in which patients are sensitive to the DNA-damaging
effects of sunlight. XP can be caused by disabling any of eight different genes. Seven of the
genes, denoted XPA–XPG, encode components of the nucleotide excision-repair pathway. A
variant form of the syndrome, XPV, corresponds to the inactivation of the gene encoding
DNA polymerase η.
transition mutations
Base changes in DNA in which a pyrimidine (C or T) is replaced by another pyrimidine, or a
purine (A or G) is replaced by another purine.
transversion mutations
Base changes in DNA in which a pyrimidine (C or T) is replaced by a purine (A or G), or a
purine is replaced by a pyrimidine.
proliferating-cell nuclear antigen
(PCNA). PCNA was first identified as a DNA sliding clamp for replicative polymerases, but
is now known to coordinate the organization of protein partners that are involved in many
processes, including DNA replication, DNA repair and cell-cycle control.
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Figure legends.
Figure 1. DNA transactions during the formation of the B cell repertoire.
The pre-immune B-cell repertoire in mice and humans is generated by site-specific
recombination of V (variable), D (diversity) and J (joining) coding segments that make up the
antigen receptor. A second wave of DNA modifications occurs in B cells participating in an
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immune response. These consist of locus-specific point mutagenesis (known as somatic
hypermutation), which modifies the rearranged V region, and a recombination process
between non-homologous repeated sequences (switch (S) regions) located upstream constant
(C) region genes (known as class-switch recombination). Somatic hypermutation and/or gene
conversion, which involves the exchange of gene segments between a rearranged V gene and
donor sequences (often non-functional (pseudogenes, ψV)), contribute to the formation of the
pre-immune repertoire in species such as chickens, sheep and rabbits.
Figure 2. Junctional diversification during V(D)J recombination at the immunoglobulin
locus.
During V(D)J recombination at the immunoglobulin locus, two pairs of coding segments with
defined signal sequences (orange and green triangles) come together to form a synapsis.
Double-strand breaks are introduced into the DNA, resulting in the generation of coding ends
that terminate in a hairpin and two signal ends that have blunt ends. The hairpin coding ends
are then opened by the Artemis-DNA-PKcs complex and, before the ends are religated by the
XRCC4-Cernunnos-ligase IV complex, extensive processing of DNA ends takes place,
creating diversity of the coding joint.  The coding ends are subjected to nucleotide trimming,
end-filling and/or protection by DNA polymerases Polλ and N-nucleotide addition by
terminal deoxynucleotidyltransferase (TdT) (heavy chain) or Polµ (light chain). Modifications
at the coding junction are represented as a black bar. Little modification occurs during signal
end joining.
Figure 3. Possible roles of DNA polymerases at V(D)J junctions.
Three possible functions of DNA polymerases during V(D)J recombination are shown,
arbitrarily represented as symmetrical configurations: a role in protecting DNA ends, by
competition with exonucleolytic degradation; a fill-in synthesis function, generating blunt
DNA ends; a role in the bridging of 3’ protruding ends. Polµ and polλ have been shown to be
able to extend DNA ends in such a primer-template configuration that shows lower stability,
since the primer encompasses a nicked DNA template.
Figure 4. The C over G targeting bias mediated by AID (60 : 40) is equalized by the
mismatch-repair pathway.
The pattern of nucleotide substitutions observed in mutated intronic JH4 sequences from
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PNAhigh Peyer’s patch B cells is shown for the genetic backgrounds indicated, and expressed
as percent of total mutations observed. Values are corrected for base composition, i.e.
normalized for a sequence with an equal content of the four bases. Data from Ung-/-Msh2-/-
and Ung-/- cells were obtained from Rada et al.98, all other data are taken from Delbos et al.65.
Deamination by activation-induced cytidine deaminase (AID) generates a C over G mutation
bias (60:40, as observed in Ung-/-Msh2-/- mice). This bias is equalized in MSH2-proficient
animals, and result in a two-fold higher targeting of A versus T mutations, whereas it is
conserved in MSH2-deficient mice.
Figure 5. Two competitive pathways for hypermutation: the MSH2-MSH6 complex
prevents UNG from performing error-free repair.
The uracils produced by activation-induced cytidine deaminase (AID)-mediated cytidine
deamination are preferentially handled by the mismatch repair complex MSH2–MSH6, when
present as a U-G mismatch (for example in the G1 phase). This prevents uracil-DNA
glycosylase (UNG) from performing error-free repair. A patch of DNA is excised by
exonuclease 1 (Exo1), and is resynthesized with low fidelity by Polη. Uracils that are carried
over into replication or that are generated in the S phase, and present in single-stranded DNA,
are processed by UNG, to generate abasic sites in the absence of a repair template. These
abasic sites are bypassed by several translesion polymerases, such as Rev1 and others that
remain to be identified. Rather than splitting hypermutation in phase I and phase II according
to Neuberger and colleagues41, this model proposes an A/T vs. G/C mutation model that is
essentially cell-cycle and/or DNA structure dependent.
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Polymerase
family
A
B
X
Y
Polymerase name
(gene name)
Pol gamma (PolG)
Pol theta (PolQ)
Pol nu (PolN)
Pol alpha (PolA)
Pol delta (PolD)
Pol epsilon (PolE)
Pol zeta (PolZ)
Pol beta (PolB)
Pol lambda (PolL)
Pol mu (PolM)
TdT
Pol eta (PolH)
Pol iota (PolI)
Pol kappa (PolK)
Rev1
Nematode
(C. elegans)
+
+
-
+
+
+
S
-
-
-
-
+
-
+
+
Mammals
(Homo sapiens)
+
+
+
+
+
+
L
+
+
+
+
+
+
+
+
Birds
(Gallus gallus)
+
+
+
+
+
+
L
+
+
-
+
+
-
+
+
Fishes
(Danio rerio)
+
+
+
+
+
+
L
+
+
+
+
+
+
+
+
Yeast
(S. cerevisiae)
+
-
-
+
+
+
S
-
Pol4
-
-
+
-
-
+
a
a S = small Rev3, protein size similar to yeast, approximately 1500 amino acids
L = large Rev3, protein size similar to humans, approximately 3000 amino acids
Table 1: Amplification of DNA polymerases in higher vertebrates
Relevant DNA transaction
(birds or mammals)
mitochondrial DNA replication
TLS ? BER ?
TLS ?
replication priming
replication
replication
TLS , SHM?
base excision repair (BER)
BER, NHEJ (V-D-J recombination),TLS ?
NHEJ (V-J recombination), TLS ?
V-D-J recombination
TLS, SHM,GC ?, homologous recombination ? 
TLS
TLS, NER ?
TLS, SHM
b
b “?” refers to processes mainly documented in vitro
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pre-immune repertoire
immune response
(repertoire diversification)
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somatic hypermutation
class switch recombination
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gene conversion
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Ig gene rearrangement
Figure 1
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Binding of RAGs
Formation of synapsis
Single-strand break, harpin
and double strand break formation,
binding of Ku70, Ku80 to DNA ends
Processing of DNA ends
(endo/exonucletidic degradation,
pol  lambda/Tdt or pol mu)
Ligation by the DNA-ligase IV
-XRCC4-Cernunnos complex
« Signal joint »
(minor processing)
« Coding joint »
(extensive end modification)
DNA-PKcs + Artemis recruitment
hairpin opening
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